XML 53 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Schedule of estimated fair value of derivatives measured by level of fair value hierarchy
The Company’s financial assets and liabilities measured and reported at fair value on a recurring basis include the following as of:
 
 
June 30, 2018
 
December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Derivative assets(1)
 
$

 
$
25,485

 
$

 
$
25,485

 
$

 
$
12,586

 
$

 
$
12,586

Derivative liabilities
 

 

 

 

 

 
265

 

 
265

Non-real estate investment(1)(2)
 

 
2,713

 

 
2,713

 

 

 

 


_____________ 
(1)
Included in the prepaid expenses and other assets line item on the Consolidated Balance Sheets.
(2)
Related to our investment in shares in a non-public company. Pursuant to our adoption of ASU 2016-01 during 2018, the Company marked the investment to fair value during the second quarter of 2018. The investment was not fair valued in 2017 and was accounted for under the cost method.
Schedule of carrying value and fair value of notes payable
The table below represents the carrying value and fair value of the Company’s notes payable as of:
 
June 30, 2018
 
December 31, 2017
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Unsecured notes payable(1)(2)
$
2,014,315

 
$
1,968,163

 
1,974,278

 
$
1,960,560

Secured notes payable
365,652

 
357,092

 
464,311

 
458,441


_________________
(1)
Amounts represent notes payable excluding net deferred financing costs.
(2)
The $400.0 million registered senior notes were issued at a discount. The discount, net of amortization, was $685 thousand and $722 thousand at June 30, 2018 and December 31, 2017, respectively, and is included within unsecured notes payable.